IMXIClinical•globenewswire•
Immix Biopharma Announces Other Serious Diseases Strategy
Sentiment:Negative (20)
Summary
– Dosing ongoing and planned in a handful of Other Serious Diseases (OSD) –
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 6, 2025 by globenewswire